Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -11.332\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CC(C)(CCO)Nc1ncnc2onc(-c3ccc(F)cc3)c12
b) CC(C)CN1CCC(=O)N([C@H](CO)Cc2ccccc2)CC1
c) CC(C)(C)Nc1nc(OCC#N)nc(N2CCCCC2)n1
Answer: c. CC(C)(C)Nc1nc(OCC#N)nc(N2CCCCC2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)(C)Nc1nc(OCC#N)nc(N2CCCCC2)n1
CC(C)(C)Nc1nc(OCC#N)nc(N2CCCCC2)n1
2-[[4-(tert-butylamino)-6-piperidin-1-yl-1,3,5-triazin-2-yl]oxy]acetonitrile